Yinxiang Hu
Guiyang, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 14 publications
MTHFD2 is required for DNA repair and implicated in LUAD radiotherapy resistance.
Journal: Journal of translational medicine
Published: September 02, 2025
HMGB1 blockade attenuates cardiac injury induced by radiotherapy combined with PD-1 inhibitor while maintaining the anti-tumor efficacy.
Journal: Apoptosis : an international journal on programmed cell death
Published: August 28, 2025
Method of Reducing Low-Dose Lung Volume in VMAT on Central Lung Cancer Planning
Journal: Zhongguo yi liao qi xie za zhi = Chinese journal of medical instrumentation
Published: April 17, 2025
Low-dose radiation as a potential strategy for alleviating lung injury caused by radiotherapy combined with immunotherapy: A preclinical study.
Journal: Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology
Published: October 16, 2024
Appropriate delay of primary tumour radiotherapy may lead to better long-term overall survival for non-small cell lung cancer treated with EGFR-TKIs.
Journal: BMC cancer
Published: March 29, 2024
PD-1 Inhibitor Aggravate Irradiation-Induced Myocardial Fibrosis by Regulating TGF-β1/Smads Signaling Pathway via GSDMD-Mediated Pyroptosis.
Journal: Inflammation
Published: February 02, 2024
Impact of thoracic tumor radiotherapy on survival in non-small-cell lung cancer with malignant pleural effusion treated with targeted therapy: Propensity score matching study.
Journal: Cancer medicine
Published: March 14, 2023
Preliminary results of randomized phase II study of etoposide plus lobaplatin or etoposide plus cisplatin with concurrent thoracic radiotherapy in the treatment of limited-stage small cell lung cancer.
Journal: Anti-cancer drugs
Published: February 02, 2023
The Effect of PD-1 Inhibitor Combined with Irradiation on HMGB1-Associated Inflammatory Cytokines and Myocardial Injury.
Journal: Journal of inflammation research
Published: September 01, 2022
Non-Small Cell Lung Cancer with Malignant Pleural Effusion May Require Primary Tumor Radiotherapy in Addition to Drug Treatment.
Journal: Cancer management and research
Published: August 12, 2022
Failure pattern and radiotherapy exploration in malignant pleural effusion non-small cell lung cancer treated with targeted therapy.
Journal: Frontiers in oncology
Published: June 21, 2022
Reasonable Timing of Radiotherapy for Stage IV Non-Small-Cell Lung Cancer During Targeted Therapy Based on Tumour Volume Change.
Journal: Frontiers in oncology
Published: May 05, 2021
Last Updated: 09/26/2026